Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,712 | 24,694 | 28,918 | 9,549 | 7,129 |
| TOTAL | $23,010 | $25,554 | $29,511 | $10,108 | $7,664 |
| Non-Current Assets | |||||
| PPE Net | 485 | 545 | 607 | 665 | 731 |
| Other Non-Current Assets | 504 | 533 | 23 | 23 | 23 |
| TOTAL | $989 | $1,078 | $630 | $688 | $754 |
| Total Assets | $23,999 | $26,632 | $30,141 | $10,796 | $8,418 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,523 | 766 | 1,034 | 879 | 1,217 |
| Accrued Expenses | 2,055 | 1,971 | 2,251 | 2,919 | 2,362 |
| Other current liabilities | N/A | N/A | 99 | 116 | 740 |
| TOTAL | $3,811 | $2,962 | $3,384 | $3,914 | $4,319 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,047 | 13,035 | 12,616 | 12,572 | 12,543 |
| TOTAL | $13,020 | $13,019 | $12,598 | $12,563 | $12,526 |
| Total Liabilities | $16,831 | $15,981 | $15,982 | $16,477 | $16,845 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67 | 66 | 62 | 54 | 15 |
| Common Shares | 17 | 16 | 15 | 5 | 130 |
| Retained earnings | -227,141 | -223,432 | -219,461 | -204,545 | -200,803 |
| Other shareholders' equity | 2,081 | 2,250 | 2,851 | -1,948 | -1,940 |
| TOTAL | $7,168 | $10,651 | $14,159 | $-5,681 | $-8,427 |
| Total Liabilities And Equity | $23,999 | $26,632 | $30,141 | $10,796 | $8,418 |